Celltrion Healthcare, Foreigners Net Sell 16,000 Shares... Stock Price -0.47%
As of 2:33 PM on the 7th, Celltrion Healthcare is trading at 85,300 KRW, down 0.47% from the previous day. This represents a 7.03% increase compared to April 10. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net sold 16,000 shares of Celltrion Healthcare, and institutions have net sold 3,000 shares, according to provisional data. Over the past five days, individual investors have net bought 263,058 shares, while foreigners and institutions have net sold 170,119 shares and 107,869 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- Will the National Pension Service Increase Its Domestic Stock Proportion? Five-Year Asset Allocation Plan to Be Finalized on May 28
- Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- Japanese Teacher Dismissed for Obscene Acts Involving Third-Grade Girl's Water Bottle
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
